Literature DB >> 28579616

Enhancement of endocytic uptake of HIV-1 virions into CD4-negative epithelial cells by HIV-1 gp41 via its interaction with POB1.

Yue Tan1, Junyi Wang1, Shan Su2, Qian Wang2, Shibo Jiang2, Lu Lu2, Ying-Hua Chen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 28579616      PMCID： PMC5518814          DOI： 10.1038/cmi.2015.38

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  9 in total

Review 1.  HIV entry and its inhibition.

Authors:  D C Chan; P S Kim
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

2.  Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells.

Authors:  A Graness; S Hanke; F D Boehmer; P Presek; C Liebmann
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

3.  HIV-1 glycoprotein 41 ectodomain induces activation of the CD74 protein-mediated extracellular signal-regulated kinase/mitogen-activated protein kinase pathway to enhance viral infection.

Authors:  Chang Zhou; Lu Lu; Suiyi Tan; Shibo Jiang; Ying-Hua Chen
Journal:  J Biol Chem       Date:  2011-10-28       Impact factor: 5.157

4.  Studies of HIV-1 envelope glycoprotein-mediated fusion using a simple fluorescence assay.

Authors:  C D Weiss; S W Barnett; N Cacalano; N Killeen; D R Littman; J M White
Journal:  AIDS       Date:  1996-03       Impact factor: 4.177

5.  HIV-1 inhibition by a peptide.

Authors:  S Jiang; K Lin; N Strick; A R Neurath
Journal:  Nature       Date:  1993-09-09       Impact factor: 49.962

6.  Identification and characterization of a novel protein interacting with Ral-binding protein 1, a putative effector protein of Ral.

Authors:  M Ikeda; O Ishida; T Hinoi; S Kishida; A Kikuchi
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

7.  Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.

Authors:  C T Wild; D C Shugars; T K Greenwell; C B McDanal; T J Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

Review 8.  Viral infections and sphingolipids.

Authors:  Jürgen Schneider-Schaulies; Sibylle Schneider-Schaulies
Journal:  Handb Exp Pharmacol       Date:  2013

9.  Identification of a human protein-derived HIV-1 fusion inhibitor targeting the gp41 fusion core structure.

Authors:  Lijun Chao; Lu Lu; Hengwen Yang; Yun Zhu; Yuan Li; Qian Wang; Xiaowen Yu; Shibo Jiang; Ying-Hua Chen
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240
  9 in total
  1 in total

Review 1.  Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.

Authors:  Jing Pu; Qian Wang; Wei Xu; Lu Lu; Shibo Jiang
Journal:  Viruses       Date:  2019-08-01       Impact factor: 5.048
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.